{"id":"W4229333219","doi":"10.14740/jmc3918","title":"Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; FOLFIRINOX; Gemcitabine; Oncology; Irinotecan; Olaparib; Internal medicine; Pancreatic cancer; Chemotherapy; Cancer; Immunotherapy; Colorectal cancer; Poly ADP ribose polymerase","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000131134,0.0005804753,0.0005289007,0.000697314,0.001080517,0.0008420327,0.0003482501,0.001471127,0.001365156],"category_scores_gemma":[0.0008451053,0.0003109477,0.000638512,0.0006021438,0.000494856,0.0005833052,0.0004372571,0.0009266395,0.0004156703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005331198,"about_ca_system_score_gemma":0.0003052377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009248657,"about_ca_topic_score_gemma":0.001137023,"domain_scores_codex":[0.9998234,0.00001813011,0.00002776353,0.00004946129,0.00002652448,0.00005470716],"domain_scores_gemma":[0.9996904,0.00006524991,0.00008497597,0.00002828835,0.00002154732,0.0001095039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0002406961,0.0001775357,0.1138994,0.00009613296,0.00007235938,0.86954,0.0004051245,0.0001385247,0.001718201,0.0001966116,0.001288262,0.01222723],"study_design_scores_gemma":[0.00002256143,0.0001508096,0.03635014,0.00002485625,0.00006983665,0.9600381,0.0002197649,0.0002526713,0.0004590076,0.0001113578,0.002285268,0.00001562765],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864653,0.008297978,0.0008550801,0.0007477851,0.00009825068,0.00006385762,0.0001627446,0.00004210134,0.003266968],"genre_scores_gemma":[0.9962223,0.002350793,0.0002617374,0.000268554,0.0002153051,0.00001510816,0.0001422153,0.0000106482,0.0005133497],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001471127,"threshold_uncertainty_score":0.004566908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03598566853732795,"score_gpt":0.3317811058234291,"score_spread":0.2957954372861012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}